Phase 2 Trial of Topical Thykamine in Adults With Mild to Moderate Atopic Dermatitis [0.03%]
特卡明治疗轻中度特应性皮炎二期临床试验
Charles Lynde,Yves Poulin,Jerry Tan et al.
Charles Lynde et al.
Atopic dermatitis is a common skin disorder for which there remains an unmet need for topical pharmacotherapies that are safe and effective. This phase 2 study assessed the efficacy and safety of 3 dosages of PUR 0110 (Thykamine; Devonian H...
Evolving Concepts in Psoriasis: Special Considerations for Patients With Skin of Color, Skin Barrier Dysfunction, and the Role of Adjunctive Skin Care [0.03%]
银屑病的新兴概念：肤色人群的特殊考虑、皮肤屏障功能障碍及辅助性皮肤护理的作用
Andrew Alexis,Heather Woolery-Lloyd,Anneke Andriessen et al.
Andrew Alexis et al.
Background: Despite considerable advances in our understanding of the pathogenesis and treatment of psoriasis, data pertaining to racial/ethnic variations, effects on barrier function, and the potential role of adjunctive...
Dermatomal Granulomatous Dermatitis and Vasculitis Following Herpes Zoster Ophthalmicus [0.03%]
带状疱疹眼病后发生的节段性肉芽肿性皮炎和血管炎
Michael Martinez,Randie Kim,John Zampella
Michael Martinez
Cutaneous granulomatous dermatoses are uncommon sequelae of herpes zoster (HZ) infection that have been documented in the literature, with granulomatous vasculitis described in rare cases. Here, we report a patient with HZ ophthalmicus who ...
Pharmacokinetic Profile, Safety, and Tolerability of Topical Berdazimer Gel, 10.3% in Patients With Molluscum Contagiosum [0.03%]
10.3％局部berdazimer凝胶治疗传染性软疣的药代动力学，安全性及耐受性
Martina Cartwright,Carolyn Enloe,Stephen Stripling et al.
Martina Cartwright et al.
Background: Berdazimer (SB206), gel 10.3% is a novel, topical, nitric oxide–releasing agent intended for molluscum contagiosum (MC) treatment. Metho...
Multicenter Study
Journal of drugs in dermatology : JDD. 2022 Oct 1;21(10):1104-1110. DOI:10.36849/JDD.6938 2022
Rohan Singh,Ajay Chatim,Aman Kankaria et al.
Rohan Singh et al.
Background: Acne vulgaris has a multifactorial pathogenesis, and combination therapy is recommended in most patients. A tretinoin 0.1%/benzoyl peroxide 3% (Tret-BPO) cream which uses a core-shell encapsulation system to e...
Shishira Jartarkar,Anant Patil,Anna Waskiel-Burnat et al.
Shishira Jartarkar et al.
Artificial intelligence (AI), a field of computer science, aims at simulating human intelligence with computers. Though AI has surpassed dermatologists in skin cancer detection, it still lags behind various other specialties like radiologis...
A Survey of Patient Attitudes Towards Topical Minoxidil in the Treatment of Hair Loss [0.03%]
脱发患者对外用米诺地尔治疗的态度调查
Dillon Nussbaum,Emily Murphy,Kamaria Nelson et al.
Dillon Nussbaum et al.
Hair loss, specifically androgenetic alopecia (AGA), is a common outpatient dermatology complaint. AGA occurs in men and women, results from the effect of dihydrotestosterone miniaturizing scalp follicles, and commonly presents with thinnin...
Marissa Contento,Jacqueline Maher,Abigail Cline et al.
Marissa Contento et al.
Background: The pathophysiology of atopic dermatitis (AD) is multifactorial, influenced by genetics, skin barrier dysfunction, and environmental stressors. There is a lack of research comparing the etiologies and patholog...
Social media use among dermatology patients is ubiquitous, with estimates of over 80% of patients using social media to learn about their dermatologic conditions. Vitiligo is an autoimmune disease leading to depigmentation with an estimated...
Annual Trends in Medicare Part D Prescription Claims for Dupilumab 2017 to 2019 [0.03%]
2017至2019年医疗保险D部分dupilumab处方索赔的年度趋势
Leena Munawar,Aislyn Oulee,Alexandra Norden et al.
Leena Munawar et al.
Disease control for moderate to severe atopic dermatitis (AD) has been primarily achieved with phototherapy and non-specific immunomodulators, cyclosporine, and methotrexate. These treatments have, however, been associated with many unfavor...